According to the Dominion Post, Mylan’s Morgantown, VA plant is restarting the production of an anti-malaria medication that is under study as a potential treatment for the COVID-19 virus.
The drug is hydroxychloroquine sulfate; the tablets are approved by the U.S. Food and Drug Administration for the treatment of malaria, lupus erythematosus, and rheumatoid arthritis.
Nicotinamide Riboside – The Key to Anti-Aging? Those who are interested, can access one of the clinical trials through this link. Of significance is the connection between aging and the increase of inflammatory process in the body. Nicotinamide Riboside shows promise for further research in this area. Nicotinamide riboside (NR), or niagen, is an alternative … Read more